![](https://emtestdot.files.wordpress.com/2020/05/godif-logo.png?w=500)
GODIF aims to determine whether the drug furosemide is an effective treatment for critically ill patients with fluid overload.
Furosemide is a diuretic, given to reduce fluid build up. Fluid build up is a common and serious complication in patients admitted to the intensive care unit (ICU). This trial will compare furosemide to a placebo.
Trial Sponsor
MD, Morten Bestle
Nordsjællands Hospitalt
morten.bestle@regionh.dk
![](https://emtestdot.files.wordpress.com/2020/09/morten-bestle-3.jpg?w=1024)
Useful Documents
- Information for patients (English)
- Read the latest GODIF newsletter
- GODIF trial publications
![](https://emtestdot.files.wordpress.com/2020/05/cric-diagrams-criteria-1-1.png?w=685)
Overview of Recruitment